Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to $13.8 million.

  • SeaStar Medical Holding's Cash & Equivalents rose 56282.42% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 56282.42%. This contributed to the annual value of $1.8 million for FY2024, which is 93352.27% up from last year.
  • As of Q3 2025, SeaStar Medical Holding's Cash & Equivalents stood at $13.8 million, which was up 56282.42% from $6.3 million recorded in Q2 2025.
  • SeaStar Medical Holding's Cash & Equivalents' 5-year high stood at $13.8 million during Q3 2025, with a 5-year trough of $13000.0 in Q2 2023.
  • Its 3-year average for Cash & Equivalents is $3.3 million, with a median of $1.8 million in 2024.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 896923.08% in 2024, then surged by 559.87% in 2025.
  • SeaStar Medical Holding's Cash & Equivalents (Quarter) stood at $176000.0 in 2023, then skyrocketed by 933.52% to $1.8 million in 2024, then skyrocketed by 658.66% to $13.8 million in 2025.
  • Its Cash & Equivalents was $13.8 million in Q3 2025, compared to $6.3 million in Q2 2025 and $5.3 million in Q1 2025.